longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Astria Therapeutics(ATXS.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

20:10 ETAscletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

prnewswire·04/27/2026 08:12
US
ATXS
0.00%
US
FBT
-0.72%
US
BBH
-0.44%
prnewswire·04/27/2026 08:12
US
ATXS
0.00%
US
FBT
-0.72%
US
BBH
-0.44%

Egetis Appoints Tiago Nunes as Chief Medical Officer

MorningStar·04/09/2026 13:30
US
ATXS
0.00%
US
NBSE.ESC
0.00%
MorningStar·04/09/2026 13:30
US
ATXS
0.00%
US
NBSE.ESC
0.00%

Egetis Therapeutics Highlights Rare Disease Focus and Commercialization Plans in 2025 Annual Report

Tip Ranks·03/24/2026 22:35
US
ATXS
0.00%
Tip Ranks·03/24/2026 22:35
US
ATXS
0.00%

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board | COSM Stock News

StockTitan·02/24/2026 17:30
US
COSM
-7.88%
US
XHE
-1.61%
US
XLV
-0.52%
StockTitan·02/24/2026 17:30
US
COSM
-7.88%
US
XHE
-1.61%
US
XLV
-0.52%

Axtria releases U.S. Incentive Compensation Benchmarking Study 2026 to aid life sciences, enhancing performance.

Unusual Whales·02/19/2026 22:28
US
ATXS
0.00%
SH
CS精准医
+1.54%
Unusual Whales·02/19/2026 22:28
US
ATXS
0.00%
SH
CS精准医
+1.54%

Will BioCryst's ORLADEYO Hit The $1 Billion Sales Mark?

rttnews·02/04/2026 21:27
US
XLV
-0.52%
US
XBI
-1.04%
US
IHE
-0.50%
rttnews·02/04/2026 21:27
US
XLV
-0.52%
US
XBI
-1.04%
US
IHE
-0.50%
© 2026 Longbridge|Disclaimer

Event Tracking

Jan26
Astria Therapeutics Inc. Secures $400 Million in Loans for Merger with BioCryst Pharmaceuticals Inc.
07:43
BioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics for $700 Million
07:10
Dec3
BioCryst Pharmaceuticals Plans to Merge with Astria Therapeutics
12:00
Nov13
Astria Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 706 K (forecast USD 10.67 M), actual EPS USD -0.5455 (forecast USD -0.39)
04:00
Astria Therapeutics released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 706 K, actual EPS USD -1.6964
04:00
Nov12
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $8.55 per Share and 0.59 Shares
13:03

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 706 K, Net Income -31.64 M, EPS -0.5455

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -33.05 M, EPS -0.5698

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -33.71 M, EPS -0.5811

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATPC
3.600
+72.25%
+1.310
LIMN
0.3019
+60.76%
+0.114
QBTX
17.520
+46.73%
+5.640
RGTX
25.845
+42.95%
+7.740
RGTU
25.800
+41.06%
+7.510
WHLR
1.315
+41.02%
+0.352
NIVF
1.040
+40.71%
+0.311
SBFM
0.5154
+40.32%
+0.148
CODX
3.270
+36.82%
+0.899
INFQ
15.050
+34.62%
+3.860
View More